News

RAIsonance Empowers Businesses and Consumers with SoundPass Technology

Multi-Factor Authentication with Signal Data Signatures is a perimeter security game-changer

Denver, CO, August 5, 2021 – RAIsonance, Inc., a family of Artificial Intelligence/Machine Learning (AI/ML)-based technology companies headquartered in the Denver Tech Center, announced the launch of one of its newest and most innovative products, SoundPass.

SoundPass is a non-medical, biometric tool using multi-factor authentication (MFA) for establishing and maintaining a bubble of perimeter security around the premises or a group of people.

Captured by the mobile app and sent to the AI/ML algorithms, a forced cough vocalization creates a signal data signature or SDS. Our proprietary AI/ML system compares the incoming SDS to the user's personal Baseline SDS for multi-factor authentication. Within minutes, if the new SDS matches the Baseline, the user receives an “Authenticated” message. SoundPass Plus users also receive a QR code for verification at locations using the SoundPass Access software.

"This simple-to-use phone app makes it easy for anyone to conduct a self-check at any time.” said Kitty Kolding, CEO of RAIsonance, Inc. "Our goal is to allow everyone to create a bubble around themselves, their loved ones, friends, even their customers and employees based on individual biometrics. No questionnaires, no medical screenings, no lab testing, no chemical sniffers, no waiting. This is exactly what SoundPass technology delivers.”

Via Apple App Store and Google Play store, SoundPass is available now to businesses, educational campuses, entertainment venues, and any facility seeking to enable smarter in-person interactions.

For more information on SoundPass please visit SoundPass.ai/.

About RAIsonance, Inc.
RAIsonance is a family of companies headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning (AI/ML)-based solutions for the biometrics, security, and healthcare diagnostics markets. Funded in part with a grant from the National Science Foundation, RAIsonance has developed technology innovations that use Signal Data Signature recognition as a biomarker for non-medical software and a new generation of diagnostic software as medical devices.

For more information on RAIsonance, please visit RAIsonance.ai/.

Media Contact
Terese Kelly
Rosica Communications
Email: terese@rosica.com
Phone: (201) 843-5600 Ext. 206


RAIsonance Launches SoundPass Biometric Security Tool

SoundPass uses artificial intelligence to create a biometric perimeter security bubble around workplaces, entertainment and consumer venues, and college campuses.

By Nathan Eddy | August 16, 2021 | mobihealth news

RAIsonance, a group of AI-powered companies focused on natural language processing and AI/ML, announced the release of SoundPass, a trio of AI apps that transform sound data signatures into biometric signal data signatures.

SoundPass uses artificial intelligence to create a biometric perimeter security bubble around workplaces, entertainment venues, public-facing businesses, and college campuses.

The product was designed to bring students back to school and employees back to the office this fall with scalable, efficient controls in place that address the challenges society is currently encountering.

The app learns the unique forced cough signature of each user, which is then securely stored as that user’s baseline for future comparison. If the signature is the same, the user gets an “authenticated” message.

However, if the signatures do not match, the user gets a “not authenticated” message, providing an early warning of a possible problem. Conditions that can alter a baseline forced cough sound include illness and environmental exposure.

The apps come in three editions, Personal, Plus and Access. Personal is free of charge. Plus costs $25 per person, per year, and generates a scannable QR code each time a user authenticates a new forced cough signature to their baseline. The Access app is used to scan the QR code of anyone using SoundPass Plus.

Founded in 2020 in response to COVID-19, and partially funded by National Science Foundation, RAIsonance’s solutions target safety, security and healthcare diagnostics markets, using signal-data signature recognition as a biomarker for human medical diagnostics and in support of safety applications.

"We see a significant opportunity going forward for many different players, some of which we’re actively working to partner with,” Kitty Kolding, CEO of RAIsonance, told MobiHealthNews. “For ourselves, given the approach we take to using AI/ML for security and health purposes, the opportunities are wide open.”

She noted RAIsonance has at least two new products in development to be released on their 2021 road map, all using the same basic capabilities they’ve developed, but serving specific, timely needs in the U.S. and the world.

RAIsonance also has a second product under development, an AI software-as-a-medical device (SaMD) diagnostic for a range of respiratory conditions.

The company recently joined Microsoft for Startups program, giving RAIsonance access to the tech giant’s technologies, including Azure, and to a streamlined path to selling alongside Microsoft and its global partner ecosystem.

“The Microsoft for Start Ups program is really incredible for a start-up,” Kolding said. “Part of the value is the series of credits they offer for software and Azure server utilization which is direct savings for us, and has allowed us to expedite our extensive AI/ML testing with very high capacity CPU and GPU servers.”


Former Neustar Executive Joins Denver AI company

Paul McLenaghan Joins RAIsonance as Head of Market Development

Denver, CO, July 23, 2021 – RAIsonance, Inc., a group of AI powered technology solutions companies which help to meet today’s critical health and safety challenges, is proud to announce Paul McLenaghan to its team as Senior Vice President, Market Development.

Before joining RAIsonance, McLenaghan spent 20 years in the advertising technology industry, most recently at Prohaska Consulting, where he worked with major ad tech platforms, publishers, and media companies on data and new product strategy. A market and business development executive with a passion for driving market disruption and transformation, McLenaghan is a versatile leader who combines an ability to generate revenue growth through interaction with external stakeholders, the ability to influence internal product innovation, and the know-how in developing go-to market strategies for new products and technology solutions.

In this role with RAIsonance, McLenaghan will be responsible for influencing adoption and utilization of RAIsonance solutions through partnerships with commercial and non-commercial organizations, as well as identifying new market opportunities for the company.

"We are thrilled to have Paul join our team," said Kitty Kolding, CEO of RAIsonance, Inc. "His background and experience with market development will help expose our company and our offerings to the key partners and markets we’re focused on as we roll out our AI/ML technology solutions."

McLenaghan also spent 15 years of his career at companies such as TARGUSinfo and Neustar where he had a track record of success creating new solutions and lines of business at the intersection of technology, data, and media.

He completed his MBA at the University of Maryland Robert H. Smith School of Business and has BA degrees in Economics and English from Villanova University. He is a dual citizen of Australia and the United States.

About RAIsonance, Inc.
RAIsonance is a family of companies headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning (AI/ML)-based solutions for the safety, security, and healthcare diagnostics markets. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use Signal Data Signature Recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. To learn more about SoundPass go to SoundPass.ai/.

Media Contact
Terese Kelly
Rosica Communications
Email: terese@rosica.com
Phone: (201) 843-5600 Ext. 206


RAIsonance, Inc. Joins Microsoft for Startups Program

RAIsonance Selected for Microsoft for Startups Program Designed to Help the World’s Most Promising B2B Startups Quickly Scale

Denver, CO, July 1, 2021 – RAIsonance, Inc., a family of Artificial Intelligence/Machine Learning (AI/ML)-based technology companies headquartered in the Denver Tech Center, dedicated to solving today’s critical health and safety challenges, announced today that they have been named the newest member of Microsoft for Startups. This global program provides the tools and resources B2B startups need to rapidly build their business. As a member in the program, RAIsonance will have exclusive access to Microsoft's technologies, including Azure, as well as a streamlined path to selling alongside Microsoft and its global partner ecosystem.

Founded in 2020 in response to COVID-19, and partially funded by National Science Foundation, RAIsonance is a family of companies dedicated to Artificial Intelligence/Machine Learning (AI/ML) based solutions for the safety, security, and healthcare diagnostics markets.

One of the company’s newest products, SoundPass, is a trio of artificial intelligence applications that transforms sound data signatures into biometric signal data signatures.

Users establish a baseline by producing a “forced cough vocalization” multiple times into the app, teaching it to recognize their unique baseline signature. Once this baseline is established, SoundPass users can conduct a self-check at any time to verify whether a change has taken place compared to their own unique baseline.

If nothing has changed, Sound-Pass generates an “authentication” message in under 2 minutes. Users of SoundPass Plus also receive a QR code that can be read by SoundPass Access software at businesses, places of worship, entertainment venues or educational campuses using the SoundPass technology to enhance their safety protocols.

If a user attempts a self-check with SoundPass and is unable to obtain an authentication, this indicates a potential risk. The most common reason for an authentication failure is that the user experienced a change in their cough signature. Conditions that can create such a change to a forced cough sound include illness and environmental exposure, among others.

With support from the Microsoft for Startups program, SoundPass will be able to roll out the SoundPass Access technology rapidly to businesses, educational campuses, entertainment venues, houses of worship or any facility seeking to enable smarter in-person interactions. This rigorous, scientific approach helps employees, customers, visitors and congregants feel more confident and comfortable when returning to in-person interactions and activities.

"We are thrilled to become a part of the Microsoft for Startups program," said Kitty Kolding, CEO of RAIsonance, Inc. "This program will provide us with exposure to thousands of businesses who will utilize our technology solutions to work toward a new normal. Our entire platform has been Azure-based from the start, so we are incredibly excited to collaborate with, and learn from the experts at Microsoft to help build our business faster and better."

"Now is the time to provide peace of mind about returning to in-person activities, and Microsoft is looking forward to working with RAIsonance to make that happen in a bigger way," said Sally Frank, WW Lead, Health & Life Sciences, Microsoft for Startups.

For more information on SoundPass, please visit SoundPass.ai/. For more information on the Microsoft for Startups Program, please visit Microsoft for Startups.

About RAIsonance, Inc.
RAIsonance is a family of companies headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning (AI/ML)-based solutions for the safety, security, and healthcare diagnostics markets. Originally funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use Signal Data Signature Recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. To learn more about SoundPass go to SoundPass.ai/.

Media Contact
Terese Kelly
Rosica Communications
Email: terese@rosica.com
Phone: (201) 843-5600 Ext. 206


RAIsonance, Inc. Announces First Medical Advisory Board

AI Technology Company Brings Together Revered Team of Healthcare Professionals from Around the Country

Denver, CO, July 1, 2021 – RAIsonance, Inc., a group of AI powered technology solutions companies which help to meet today’s critical health and safety challenges headquartered in the Denver Tech Center, is proud to announce that it has seated its very first Medical Advisory Board to commence its two-year term starting June, 2021.

The distinguished members include:

  • Rodolfo Aldir, MD, FACC, FCCP; Medical Advisory Board Chair; Interventional Cardiologist with Orlando Health
  • Lewis Marshall, MD, JD, MS, FAADM, FAAEP, FACP, FACHE, FCLM; Advisory Board Member; Chief Medical Officer at NYC Health & Hospitals / Lincoln; Member and Fellow of the American Academy of Disaster Medicine
  • Andrea Keener, PhD, LMHC, MCAP, Long COVID Advisory Board Chair
  • Jeanne M. LeBlanc, PhD, ABPP, R. Psych; Advisory Board Member; Private Practice - Clinical Neuropsychology and Rehabilitation
  • Frederick L. Slone, MD, FAADM; Advisory Board Member; Associate Professor at University of South Florida College of Medicine, Member and Fellow of the American Board of Disaster Medicine
  • Ryan Chakra, MD; Advisory Board Member; Senior Medical Director at BD
  • Greg Cohen, DO, FACOFP; Advisory Board Member; Lucas County Health Center Medical Clinics in Chariton, Iowa
  • Heidi P. Cordi, MD, MPH, MS, EMTP, FACEP, FAADM; Advisory Board Member; Core Faculty for the Division of Emergency Medical Services, Associate Director of the EMS Fellowship Program, and EMS Coordinator for Rensselaer County, Assistant Professor of Medicine at Columbia University Medical Center, Assistant Professor of Clinical Medicine and Associate Medical Director of Emergency Medical Services at New York Presbyterian Hospital, Medical Director of Mohawk Ambulance in Albany; Member and Fellow of the American Academy of Disaster Medicine
  • Elizabeth Maxwell-Schmidt, MS, MD, FAAEP, FACEPMD; Advisory Board Member; Emergency Medicine Specialist in Annapolis, MD

“We are incredibly gratified to have attracted such an esteemed team of brilliant medical professionals to serve on our Medical Advisory Board,” said RAIsonance’s Chief Medical Officer and Chief Strategy & Planning Officer Maurice Ramirez, DO, Ph.D. “With their guidance and support, we will be extremely well-positioned to bring our groundbreaking AI/ML technologies to market. As we seek to make a meaningful impact on the markets we serve, our Advisory Board will provide us with the essential insights we’ll need to make products that serve practitioners and patients all over the US, and indeed around the world.”

Founded in 2020 in an effort to impact COVID-19, and partly funded by National Science Foundation, RAIsonance is structured as a group of separate companies dedicated to Artificial Intelligence/Machine Learning (AI/ML) based solutions for the safety, security, and healthcare diagnostics markets. “We’re incredibly fortunate to have the opportunity to work with and learn from these expert clinicians,” said Kitty Kolding, CEO of RAIsonance, Inc. “Each individual brings unique perspective and invaluable expertise that will shape our product concepts and specialized technologies as we continue our work in health, wellness, biometrics and safety. It’s hard to overstate how thrilled we are to be working with a team of advisors like this one.”

For more information on RAIsonance, please visit RAIsonance.ai/